title: [Diagnosis and satisfactory surgical treatment of a jejunal stromal tumor].
abstract: GIST is the most common mesenchymal tumor of the gastrointestinal tract. The discovery of KIT proto-oncogene mutations in the pathogenesis of this tumor, and the development of imatinib mesylate, a specific inhibitor of KIT tyrosine kinase function have revolutionized the treatment of GIST. We present the clinical case of a patient with an upper digestive bleeding secondary to a jejunal GIST. Therapeutic options are highlighted.
authors.affiliation: Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario de Puerto Real, Puerto Real (Cádiz), Ctra. Nal. IV, Km. 665, España 11510. marinlm@hotmail.com
authors.forename: L M
authors.initials: LM
authors.lastname: Marín-Gómez
authors.forename: V
authors.initials: V
authors.lastname: Vega-Ruiz
authors.forename: M A
authors.initials: MA
authors.lastname: García-Ureña
authors.forename: M I
authors.initials: MI
authors.lastname: Moreno García
mesh_terms: D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis* / Q000601:surgery*; D006801:Humans; D007580:Jejunal Neoplasms / Q000175:diagnosis* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D000090063:Proto-Oncogene Mas